Bionxt Solutions Inc (BNXTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,862 | -1,167 | -5,721 | -3,919 | -2,867 |
| Depreciation Amortization | 34 | 17 | 145 | 114 | 78 |
| Accounts receivable | 122 | 139 | 127 | 97 | 68 |
| Accounts payable and accrued liabilities | 216 | 110 | 98 | -247 | -191 |
| Other Working Capital | 164 | 237 | 243 | -145 | -105 |
| Other Operating Activity | 70 | -68 | 1,280 | 1,216 | 939 |
| Operating Cash Flow | $-1,256 | $-732 | $-3,828 | $-2,885 | $-2,078 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 41 | N/A | 75 | -87 | -87 |
| Investing Cash Flow | $41 | $N/A | $75 | $-87 | $-87 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -156 | -157 | -157 |
| Common Stock Issued | 1,252 | 569 | 4,437 | 3,761 | 2,669 |
| Other Financing Activity | -77 | -46 | -359 | -285 | -191 |
| Financing Cash Flow | $1,175 | $524 | $3,921 | $3,319 | $2,322 |
| Exchange Rate Effect | 0 | 0 | 1 | -1 | 0 |
| Beginning Cash Position | 266 | 270 | 101 | 102 | 101 |
| End Cash Position | 226 | 61 | 269 | 447 | 259 |
| Net Cash Flow | $-40 | $-208 | $169 | $345 | $157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,256 | -732 | -3,828 | -2,885 | -2,078 |
| Capital Expenditure | N/A | N/A | -149 | -87 | -87 |
| Free Cash Flow | -1,256 | -732 | -3,977 | -2,973 | -2,165 |